News Image
CNBCTV18

Q3 Results LIVE Updates: Nazara Tech shares decline 2%; Trent gains ahead of earnings

Published on 04/02/2026 10:57 AM

The stock is currently down 1.9%>

Net Profit down 35.8% At ₹8.8 Cr Vs ₹13.7 Cr (YoY)

Revenue down 24% At ₹406 Cr Vs ₹534.7 Cr (YoY)

EBITDA up 80.7% At ₹67.4 Cr Vs ₹37.3 Cr (YoY)

Margin At 16.6% Vs 7% (YoY)

Vipul Mathur, Welspun Corp On CNBC-TV18:

All The EPC Contracts Are In Place But It Was Calibrated Recently Due To Funds Shortage

Funds Have Started Coming In So Expect Things To Normalise

Will Definitely Achieve Rs 2,500 Cr EBITDA In FY26

In FY27, Sintex Could Be A Turnaround Story & Achieve `1,000 Cr Revenue & Will Break Even

Trent shares are currently up 1.6%.

The company is set to report its Q3 results today.

Sheela Foam shares gained over 16% in trade today.

It reported positive earnings across all parameters in the third quarter, while its net profit surged over three times.

here

Tarun Garg, Hyundai Motor On CNBC-TV18:

Expect Q4 To Be Much Better, Momentum Seems To Be Very Strong

Co Expected To Outperform Industry Growth Of 5–6% In FY27

Export Continues To Be A Strong Pillar Of Growth

Open To Exploring Opportunities In The EU, Especially Following The Recent FTA

Plan To Raise Export Contribution To 30% By FY30 From The Current 24%

The stock is currently down 6.6%, reacting to its Q3 results

Net Profit down 23% At ₹57 Cr Vs ₹74 Cr (YoY)

Revenue up 6.3% At ₹1,588 Cr Vs ₹1,496 Cr (YoY)

EBITDA up 2.1% At ₹205.5 Cr Vs ₹201.2 Cr (YoY)

Margin At 12.9% Vs 13.4% (YoY)

The stock is currently up 1.7%.

Net Profit at ₹623.84 Cr Vs CNBC-TV18 poll of ₹608 Cr

Revenue at ₹3,709.9 Cr Vs CNBC-TV18 poll of ₹3,705 Cr

EBITDA at ₹894.4 Cr Vs CNBC-TV18 poll of ₹890 Cr

Margin at 24.1% Vs CNBC-TV18 poll of 24%

Net Profit up 11.9% at ₹623.84 Cr Vs ₹557 Cr (YoY)

Revenue up 10.1% at ₹3,709.9 Cr Vs ₹3,369 Cr (YoY)

EBITDA up 12% at ₹894.4 Cr Vs ₹798 Cr (YoY)

Margin at 24.1% Vs 23.7% (YoY)

The stock is currently down 4.8%, reacting to its Q3 results.

Net Profit marginally down 0.3% at ₹92.1 Cr vs ₹92.4 Cr (YoY)

Revenue up 24% at ₹624 Cr vs ₹503.4 Cr (YoY)

EBITDA up 23.4% at ₹134.4 Cr vs ₹108.9 Cr (YoY)

Margin at 21.5% vs 21.6% (YoY)

Sheela Foam shares are currently up 15.4%.

Net Profit up 213% at ₹52.57 Cr vs ₹16.8 Cr (YoY)

Revenue up 11.1% at ₹1,075 Cr vs ₹967 Cr (YoY)

EBITDA up 30% at ₹115 Cr vs ₹88 Cr (YoY)

Margin at 11% vs 9.11% (YoY)

 

The stock is currently down 2.7%.

Net Profit down 82.2% At ₹121 Cr Vs ₹680 Cr (YoY)

Revenue up 3.1% At ₹1,928 Cr Vs ₹1,922 Cr (YoY)

EBITDA down 2.3% At ₹230 Cr Vs ₹235 Cr (YoY)

Margin At 11.6% Vs 12.2% (YoY)

Labour Code Impact at ₹44.7 Crore

The stock declined 2% just after market open.

While net interest income and pre-provision operating profit were broadly in line with expectations, growing close to 20% year-on-year, provisions rose sharply by about ₹1,400 crore, leading to higher-than-estimated credit costs.

here

Shares of Mankind Pharma and AB Capital gained nearly 2% each at market open on Wednesday.

The stocks are reacting to their Q3 results.

Nomura on Exide:

Upgrade to Buy, Target Price Rs 398

3Q EBITDA largely in line with est.

Auto growth remains healthy, Industrial to recover

Valuations have turned attractive at 10x FY28F core EPS given a 17% EPS CAGR over FY26-28F

CLSA on Bajaj Fin:

Outperform, Target Price Rs 1200

3Q PPOP in line, while credit costs were higher as co took a one-time Rs14bn extra provision to strengthen its balance sheet.

Excluding this one-time provision, credit costs were c.5bps below estimate.

Net slippage was at 1.4%, down 80bps YoY.

AUM growth moderated from 24% the prior quarter to 22% in 3Q, as previously guided by management.

Segment-drivers of growth remain the same: healthy growth in secured and unsecured consumer and rural loans, offset by a run-down in two-wheeler (2W) and SME loans.

NIM was largely steady at 9.6% while the expense ratio was largely unchanged QoQ.

MS On AB Capital:

‘ Overweight’ Call, Target Price At Rs 432/Sh

Strong Execution Across NBFC, Life Insurance And Housing Finance

Asset quality improvement and better loan growth in NBFC

Life Insurance Margin Expanded Despite GST Impact

HFC Benefited From Operating Leverage And Strong Disbursements

Bernstein On Bajaj Finance:

Underperform Call, Target Price At Rs 750/Sh

Provisioning Surged As Co Restored PCR To Pre-Covid Levels

Regular Credit Costs Are Moderating Sequentially

Asset Quality Metrics Remain Stable Despite Higher Provisioning

Credit Costs Expected To Normalise In Coming Quarters

MS On Bajaj Finance:

Overweight Call, Target Price At Rs 1,195/Sh

Credit Costs Expected To Decline Sharply As Stressed Loan Formation Eases

Improving Asset Quality Should Support Stronger Loan Growth Ahead

FY26 Est Trimmed Due To Higher Coverage, But EPS CAGR >25% Intact

Jefferies On Mankind Pharma:

Buy Call, Target Price At Rs 2,900/Sh

Q3 Performance Broadly In-line With Estimates

Organic Rx Growth Improved To 9.1%, Reversing Recent Slowdown

Mgmt Confident As Field-force Restructuring & BSV Integration Complete

Chronic Therapies Growing At Mid-teens, Acute Portfolio Expected To Recover

Jefferies On Pidilite:

Hold Call, Target Price At Rs 1,655/Sh

Q4 PAT Growth Of 12% YoY, Broadly In-line With Expectations

Vol Growth Healthy At 9%, Sustained At 8–10% Over Last 7 Quarters

B2C Vols Strong At 10% YoY, While B2B Lagged Due To Export Weakness

Gross Margin Expanded 250 bps YoY On Softer VAM Prices

OPM Improved 40 bps YoY, FY27 Valuation Rich At 53x PE

Jefferies On Varun Bev:

Maintain Buy Call, Target Price Cut To Rs 550/Sh

India Realisations Declined 4% YoY, Negative Surprise Due To Heavy Discounting

Launch Of `10 Price Packs & Expansion Of Higher-Vol Packs Implemented

Mgmt Confident On Margin Protection, Expects Strong CY26 With Normal Summer

The company’s third quarter earnings came in on Tuesday. Accelerated expected credit loss provisioning emerged as a key negative for Q3.

here

Welcome to CNBC-TV18’s LIVE Blog on Q3 Results. Watch this space for LIVE Updates on Q3 results, management commentary, analyst views, stock reactions and more.NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.